Technology is wonderful, great, and
holds many promises. Getting there will be the challenge and making
it all work together still has to be worked out. This blog uses two
articles and a previous blog of mine to preview some of the
possibilities.
The first article points out what
nanotechnology has in store for those of us with diabetes. It has
had success in monitoring cancer in livestock and work is now being
focused on diabetes. Both will require additional testing to pass
FDA approval, but the future looks very promising. Using carbon
nanotubes, hollow, one nanometer-thick cylinders made of pure carbon
is drawing great interest as sensors.
Michael Strano, the Carbon P. Dubbs
Professor of Chemical Engineering at MIT has his labs working on
sensors for both short-term and long-term usage within the automatic
pancreas. His lead person, Nicole Iverson, is working to make the
sensors accurate enough to provide glucose readings that can work
with the automatic pancreas, but as of yet the results have not been
accurate enough. These sensors would be implanted under the skin and
would provide data directly to the insulin pump so that it could
start and stop when needed. Not only would there be no more finger
pricking, but only the removal and re-implanting of new sensors after
more than one year of use.
In mobile health apps and home
monitoring, doctors will not need to see patients as often for acute
problems and follow up visits. Presently, to make this happen,
real-world clinical evidence will be needed to confirm the mobile
health benefits. Then the apps will be on solid ground for patients,
physicians, and payers. The central idea would mean that this would
promote patient participation and partnership in their care.
In addition to reducing the number of
unnecessary visits to physicians' offices and emergency departments,
this would decrease the cost of care. Today, they noted, more than a
third of physician office visits are related to an acute condition,
and care for up to a quarter of patients presenting at emergency
departments could have been managed in the ambulatory-care setting.
Most mHealth devices have existed for all of the most common acute
conditions and have the potential to allow individuals to forgo an
office or emergency department visit through safe, effective and
informed management in the home.
On July 18, 2013, I wrote a blog about
people with type 2 diabetes that became microexperts. They would be
allowed to self prescribe medications and do home A1C tests and have
insurance reimbursement. Since then, I have heard from four doctors,
two who were very much against this and two more that could accept
this provided that the rules were in place and enforced. Three
people with type 2 diabetes thought the idea was reasonable, but two
were not enthused about the rule idea.
As far as I am concerned, the rules are
necessary to prevent abuse and keep the system working properly.
With the potential for new technology, mHealth, and other programs,
the future does hold out hope for ways to get by even during a doctor
shortage. If the new sensor technologies come to fruition, mobile
health technologies continue to improve, the patients will benefit,
costs may indeed come down and emergency rooms may not be utilized
for problems that can be solved at home.
I would encourage everyone to follow
the links and read about the possibilities.
No comments:
Post a Comment